What is Ageless Serums?
Ageless Serums operates at the intersection of advanced dermatology and professional aesthetic technology. The company specializes in the development and distribution of high-performance serums specifically engineered for hydrodermabrasion devices. By utilizing medical-grade aqua and potent active ingredients—such as their proprietary Salicylic Wash and Peptide Infusion lines—the firm provides essential tools for med spas and skincare professionals. Their business model is built upon a dual-pillar strategy: delivering superior, clinically-validated formulations while providing comprehensive educational support to practitioners. This focus on professional-grade efficacy ensures that Ageless Serums remains a preferred partner for clinics aiming to enhance their service offerings and patient outcomes through high-quality, reliable skincare technology.
How much funding has Ageless Serums raised?
Ageless Serums has raised a total of $52K across 1 funding round:
Debt
$52K
Debt (2021): $52K with participation from PPP
Key Investors in Ageless Serums
PPP
Public-Private Partnership
What's next for Ageless Serums?
With the infusion of $52K, Ageless Serums is poised to accelerate its market penetration and operational footprint. The strategic roadmap likely involves expanding its distribution network to reach a broader base of med spas and dermatological clinics, while simultaneously investing in R&D to refine its growth factor infusion portfolio. As the company transitions through this significant Series B/C stage, the focus will shift toward optimizing supply chain efficiencies and deepening its educational outreach programs. By maintaining its commitment to exceptional pricing and product quality, Ageless Serums is well-equipped to capture a larger share of the rapidly growing professional skincare market, setting the stage for sustained long-term growth and potential future market consolidation.
See full Ageless Serums company page
